Loncastuximab Tesirine and Rituximab as Bridging Therapy Before Standard-of-care CAR-T Therapy in Patients With Large B-cell Lymphoma (CORAL)
Clinical trial NCT06788964 · RECRUITING
Trial details
- NCT number
- NCT06788964
- Sponsor
- University of Utah
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-25
- Primary completion
- 2027-03-01
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.